CollaGenex Pharmaceuticals, West-ward Settle Patent Suit

Law360, New York (November 10, 2003, 12:00 AM EST) -- Dental and dermatological drugmaker CollaGenex and generic drugmaker West-ward Pharmaceutical Corporation settled all their pending litigation concerning patents for a periodontitis treatment, the two companies said Monday.

CollaGenex had sued West-ward and other defendants in the United States District Court for the Eastern District of New York, alleging that West-ward infringed CollaGenex's patents for Periostat for the treatment of adult periodontitis.

CollaGenex's complaint also alleged that West-ward infringed CollaGenex's patent rights under the Hatch-Waxman act by submitting an Abbreviated New Drug Application with the Food and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.